VSTM Verastem Inc
23,015
$12.02
$0.17
(1.44%)
| Watchers | 23,015 |
| 52-Wk Low | $4.68 |
| 52-Wk High | $15.18 |
| Market Cap | $299.9M |
| Volume | 91,355.00 |
| 52-Wk High | $15.18 |
| 52-Wk Low | $4.68 |
Verastem Oncology Reports First Quarter 2024 Financial Results and Highlights Recent Business UpdatesBusiness Wire • 4 days ago
Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced business updates and reported financial results for the...
Share to Feed
Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced that its management team will participate in a fireside...
Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced the appointment of John Hayslip, M.D., an accomplished...
GenFleet Therapeutics Announces Potent Anti-tumor Efficacy of GFH375, an Oral KRAS G12D (ON/OFF) Inhibitor, and its Potential in Combination Therapy with RAF/MEK Clamp at 2024 AACR Annual Meeting...
Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced the grant of stock options to purchase 35,000 shares of...
Mizuho Securities analyst Graig Suvannavejh maintained a Buy rating on Verastem (VSTM Research Report) on March 25 and set a price target of $36...
This price move could indicate a change in the trend, and may be a sell signal for investors...
This is a Bullish indicator signaling VSTM's price could rise from here. Traders may explore going long the stock or buying call options...
This price move could indicate a change in the trend, and may be a buy signal for investors...
This price move could indicate a change in the trend, and may be a buy signal for investors...